Pay in 4 interest-free payments of $6.71 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
ResMed CEO: Big Pharma is squarely focused on GLP-1 medications right now Image courtesy of ResMed ResMed CEO Mick Farrells stance on the issue is that the latest advances in both Big Tech and Big Pharma can potentially bring incredible numbers of new patients into the healthcare system where ResMed is uniquely positioned to provide ongoing care at home. Patients are voting with their wallets and respiratory therapists and physicians are voting with their recommendations and their prescriptions. During the companys first-quarter earnings call, Farrell said the company is laser-focused on growing the market to help people get on the therapy they need and on a pathway to better sleep, better health, and better long-term care
GLP-1 receptor activation occurs not only in the gut but also in the brain's sleep-regulating centers
[19] Glutathione mesotherapy Despite the lack of published literature on the efficacy and methodology of using glutathione solution as mesotherapy, it is widely practiced by dermatologists for the treatment of melasma and other facial melanoses
2019 was a big year for the topic of gut-brain-skin connection and for good reason
Detoxification & Liver Support Binds to toxins and free radicals, flushing them from the body for deep cellular cleansing
Similarly, our study revealed that metformin increased GLP-1R protein level in PA-treated HUVECs
